Posted by AGORACOM-JC
at 3:40 PM on Monday, July 6th, 2020
SPONSOR: CardioComm Solutions (EKG: TSX-V) – The heartbeat of cardiovascular medicine and telemedicine. Patented systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals and call centres to access and manage patient information in a secure and reliable environment.
Digital Health Funding Shatters Funding Records Despite COVID Economy
Despite COVID-19, digital health funding shattered all previous venture capital funding records for the sector by raising $6.3 billion in the first half of the year (1H), according to Mercom Capital Group.
The Austin, TX-based firm reported that the digital health funding in 1H was 24% higher than the $5.1 billion the space raised in the first half of 2019, despite the pandemic disrupting the economy
Despite COVID-19, digital health funding shattered all previous venture capital funding records for the sector by raising $6.3 billion in the first half of the year (1H), according to Mercom Capital Group.
The Austin, TX-based firm reported that the digital health funding in 1H was 24% higher than the $5.1 billion the space raised in the first half of 2019, despite the pandemic disrupting the economy. Mercom Capital Group is previewewed this data in advance of its upcoming 1H Digital Health Funding and M&A Report, which is expected to be published July 13.
Interestingly enough, venture funding reached $2.8 billion during the second quarter of 2020, an 11% decrease year-over-year compared to $3.1 billion raised in Q2 2019. Healthcare practice-centric digital health companies received 34% of the funding in Q2 2020, raising $947 million in 56 deals, and consumer-centric digital health companies accounted for 66% of the funding, raising $1.8 billion in 105 deals.
“Adoption of digital health technologies and products have accelerated since the COVID-19 outbreak, which is reflected in the funding spike in the first half of the year. Telehealth hype has been backed by $2 billion in venture funding with no signs of slowing down,†said Raj Prabhu, CEO of Mercom Capital Group.
This confirms what MD+DI has previously reported regarding telemedicine trends that emerged during the early days of the pandemic.
Other categories that received significant funding during the second quarter include mHealth apps, analytics, wellness, and medical imaging, Mercom reported.
The top-funded digital health categories in 1H 2020 were: telehealth with $1.9 billion, followed by analytics with $826 million, mHealth apps with $794 million, clinical decision support with $545 million, healthcare service booking with $326, and wearable sensors with $321 million.
The top telehealth VC deals in 1H 2020 included: $194 million raised by Amwell (formerly American Well), $155 million raised by KRY, $144 million raised by Zhiyun Health, $100 million raised by Mindstrong, and $93 million raised by Virta Health. Telehealth funding was distributed in 85 companies during 1H 2020.
The top overall digital health VC deals in 1H 2020 included: $285 million raised by ClassPass, $250 million raised by Alto Pharmacy, $194 million raised by Amwell, $155 million raised by KRY, and $150 million raised by Concerto HealthAI. Digital Health funding was distributed in 27 different countries in 1H 2020.
Mercom Capital Group is a global communications and consulting firm that produces funding and market intelligence reports covering a variety of “cleantech” sectors.
Posted by AGORACOM-JC
at 11:54 AM on Monday, July 6th, 2020
Entered into an option agreement to acquire 100% of License 023940M which is strategically positioned between the Kingsway North and South claim blocks in the emerging Gander gold belt
The acquisition of the Property increases the Company’s landholdings in the district to 308 claims or approximately 77 square kilometres
TORONTO, July 06, 2020 — Labrador Gold Corp. (TSX-V: LAB) (“LabGold†or the “Companyâ€)  is pleased to announce that it has entered into an option agreement to acquire 100% of License 023940M ( the “Propertyâ€) which is strategically positioned between the Kingsway North and South claim blocks in the emerging Gander gold belt. The acquisition of the Property increases the Company’s landholdings in the district to 308 claims or approximately 77 square kilometres.
Property Highlights
Comprises 44 claim units contiguous with Kingsway North and South (see Figure 1)
Hosts the Cracker gold occurrence where grab samples from trenching range from 1.8 g/t Au to 61.73 g/t Au and channel samples range from <5ppb to 1.89 g/t Au (see Table 1)
Historical soil sampling show gold concentrations in samples of <5ppb to 787 ppb (0.787 g/t Au), including 19 samples over 100 ppb (0.1 g/t Au)
Historical till sampling in the northern portion of the Property close to the boundary with Kingsway North, show gold concentrations in samples of 0.11 g/t to 1.61 g/t and gold grain counts of 7 to 60 grains
Table 1. Highlights of historical rock sampling on the property.
Sample ID
Sample Type
Length
Au (g/t)
21027
Grab
N/A
3.97
21028
Grab
N/A
4.74
21029
Grab
N/A
1.80
NK-1
Grab
N/A
61.73
21034
Grab
N/A
3.64
21038
Grab
N/A
1.044
22127
Channel
0.5m
1.89
22128
Channel
0.5m
0.37
Note that grab samples are select samples and are not necessarily representative of gold mineralization found on the property. Channel sample lengths are not necessarily true widths. The Company has reviewed the assay certificates in the following assessment report and is satisfied that the results are accurately reported Source: Saunders, J. and Pollet ,F. 2003 Second year assessment report on the prospecting activity on the South Pond Property License 7155M northeastern Newfoundland area NTS 2/E2.
“Optioning this strategic Property consolidates LabGold’s land position in the Gander gold belt and adds a significant gold occurrence to the property package. The Cracker showing is another gold occurrence associated with the Appleton Fault Zone, a crustal-scale structure that we believe to be a major control of gold in the district,†said Roger Moss, President and CEO of LabGold. “We will include the Property in our exploration plans for this summer with work expected to begin around mid-July.â€
LabGold can earn an initial 75% undivided interest as follows:
Payment of $18,000.00 and issuing 30,000 common shares, within 5 business days of TSX Venture Exchange acceptance of the option agreement;
Payment of $36,000, issuing 90,000 shares and undertaking $100,000 work expenditure on or before the first anniversary of the option agreement;
Payment of $75,000 issuing 120,000 shares and undertaking $250,000 work expenditure on or before the second anniversary of the option agreement;
Payment of $90,000, issuing 150,000 shares and undertaking $650,000 work expenditure on or before the third anniversary of the option agreement;
If the Company has exercised the 75% option and satisfied all payment requirements, the Company has the Option to acquire the remaining 25% interest as follows:
Payment of $240,000 and undertaking work expenditure of $1,000,000 on or before the fourth anniversary of the date of this agreement, provided that the cash payment requirement may be fulfilled by the Company at its discretion by the issuance of common shares of equal value.
If the Company exercises the 75% Option but does not exercise the 25% Option by the 4th Anniversary, the parties will be associated in an unincorporated joint venture for the purpose of exploring and, if warranted, developing the Property (the “Joint Ventureâ€). The terms and conditions of the Joint Venture shall be on industry standard terms and will be more fully laid out in an Option and Joint Venture Agreement.
The technical content of this news release was approved by Roger Moss Ph.D., P.Geo, President and CEO of the Company and a qualified person as defined by National Instrument 43-101.
About Labrador Gold:
Labrador Gold is a Canadian based mineral exploration company focused on the acquisition and exploration of prospective gold projects in the Americas.
In early March 2020, Labrador Gold acquired the option to earn a 100% interest in the Kingsway project in the Gander area of Newfoundland. The property is along strike to the northeast of New Found Gold’s discovery of 92.86 g/t Au over 19.0 metres on their Queensway property. (Note that mineralization hosted on adjacent or nearby properties is not necessarily indicative of mineralization hosted on the Company’s property). The two licenses comprising the Kingsway project cover approximately 16km of the Appleton fault zone which is associated with gold occurrences in the region, including the New Found Gold discovery. Historical work over the area covered by the Kingsway licenses shows evidence of gold in till, vegetation, soil, stream sediments, lake sediments and float. Infrastructure in the area is excellent located just 18km from the town of Gander with road access to the project, nearby electricity and abundant local water.
The Hopedale property covers much of the Florence Lake greenstone belt that stretches over 60 km. The belt is typical of greenstone belts around the world but has been underexplored by comparison. Initial work by Labrador Gold during 2017 show gold anomalies in soils and lake sediments over a 3 kilometre section of the northern portion of the Florence Lake greenstone belt in the vicinity of the known Thurber Dog gold showing where grab samples assayed up to 7.8g/t gold. In addition, anomalous gold in soil and lake sediment samples occur over approximately 40 kilometres along the southern section of the greenstone belt (see news release dated January 25th 2018 for more details).
The Ashuanipi gold project is located just 35 km from the historical iron ore mining community of Schefferville, which is linked by rail to the port of Sept Iles, Quebec in the south. The claim blocks cover large lake sediment gold anomalies that, with the exception of local prospecting, have not seen a systematic modern day exploration program. Results of the 2017 reconnaissance exploration program following up the lake sediment anomalies show gold anomalies in soils and lake sediments over a 15 kilometre long by 2 to 6 kilometre wide north-south trend and over a 14 kilometre long by 2 to 4 kilometre wide east-west trend. The anomalies appear to be broadly associated with magnetic highs and do not show any correlation with specific rock types on a regional scale (see news release dated January 18th 2018). This suggests a possible structural control on the localization of the gold anomalies. Historical work 30 km north on the Quebec side led to gold intersections of up to 2.23 grams per tonne (g/t) Au over 19.55 metres (not true width) (Source: IOS Services Geoscientifiques, 2012, Exploration and geological reconnaissance work in the Goodwood River Area, Sheffor Project, Summer Field Season 2011). Gold in both areas appears to be associated with similar rock types.
Following completion of this private placement, the Company has 85,610,451 common shares issued and outstanding and trades on the TSX Venture Exchange under the symbol LAB.
The technical content of this news release was approved by Roger Moss Ph.D., P.Geo, President and CEO of the Company and a qualified person as defined by National Instrument 43-101.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements: This news release contains forward-looking statements that involve risks and uncertainties, which may cause actual results to differ materially from the statements made. When used in this document, the words “mayâ€, “wouldâ€, “couldâ€, “willâ€, “intendâ€, “planâ€, “anticipateâ€, “believeâ€, “estimateâ€, “expect†and similar expressions are intended to identify forward-looking statements. Such statements reflect our current views with respect to future events and are subject to risks and uncertainties. Many factors could cause our actual results to differ materially from the statements made, including those factors discussed in filings made by us with the Canadian securities regulatory authorities. Should one or more of these risks and uncertainties, such as actual results of current exploration programs, the general risks associated with the mining industry, the price of gold and other metals, currency and interest rate fluctuations, increased competition and general economic and market factors, occur or should assumptions underlying the forward looking statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, or expected. We do not intend and do not assume any obligation to update these forward-looking statements, except as required by law. Shareholders are cautioned not to put undue reliance on such forward-looking statements.
Posted in Featured, Labrador Gold | Comments Off on Labrador Gold $LAB.ca Expands Kingsway to 77 Square Kilometres With Option Agreement $RIO.ca $WHM.ca $SIC.ca $NXS.ca $NVO.ca
Posted by AGORACOM-JC
at 11:24 AM on Monday, July 6th, 2020
Announced a purchase order of 20,000 COVID-19 test kits from a Canadian based mining company with operations worldwide. This PO is for one of their Latin American mine operations
Total gross sales amount is approximately $850,000 CDN, excluding shipping and courier fees
The Company has secured all requested testing kits, swabs, tubes, and the PCR machines
TORONTO, July 06, 2020 – Datametrex AI Limited (the “Company” or “Datametrex“) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce a purchase order (the “PO”) of 20,000 COVID-19 test kits from a Canadian based mining company (the “Purchaser”) with operations worldwide. This PO is for one of their Latin American mine operations.
The total gross sales amount is approximately $850,000 CDN, excluding shipping and courier fees. The Company has secured all requested testing kits, swabs, tubes, and the PCR machines. All of the items will be delivered directly to the mining company at their operating site in Latin America in mid-July. The Company anticipates little or no up front costs associated with the sale of these kits.
“Datametrex is assisting with the implementing of test kits as it is a fundamental response to the pandemic, and those mining companies that have been able to test more comprehensively have had greater success,” says Marshall Gunter, CEO of the Company. “The reasoning is simple: An individual who tests positive can be isolated until they recover, and their contacts may be traced and similarly tested and isolated, effectively reducing the rate of transmission.”
Under the terms of the PO, Datametrex will provide the Purchaser with 20,000 units of the COVID-19 qPCR Detection Kits manufactured by 1drop Inc. (“1drop”), 20,000 Universal Transport Medium (UTM®), Sterile Swabs with 16x100mm and Skirted Tubes. The Company also sold two (2) Real-Time Polymerase Chain Reaction Detection System (“PCR”) machines along with software to ensure optimal assay performance of the samples.
Some Latin American countries are seeing shocking unemployment figures as the pandemic has caused hunger to rise in the region. The fallout from the pandemic is being felt hardest in Latin America, and has seen an almost three-fold rise in the number of people requiring government assistance, and among urban communities in low and middle-income countries, which are being dragged into destitution by job losses, especially in the mining sector. Millions of people are out of work in Brazil, Chile and Colombia, which have all attempted to re-open sectors of their economies but were hit with fast-spreading infections.
About 1drop Inc.
1drop Inc. aims to provide a solution to manage health with a drop of fluid. It has the key technologies for becoming a global leading company in the field of smart health care. 1copy™ COVID-19 qPCR Multi Kit can reduce the risk of asymptomatic and latent infection of COVID-19 by a single virus level limit of detection. Additional information on 1drop Inc. is available at www.1drop.co.kr
About Datametrex
Datametrex AI Limited is a technology-focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational Health and Safety goals with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain.
Marshall Gunter – CEO Phone: (514) 295-2300 Email: [email protected]
Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.
Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.
Posted by AGORACOM-JC
at 9:49 AM on Monday, July 6th, 2020
We’re inviting you to join the KABN North America Showcase presented by company Leadership Team Â
Join us as we provide the business, technology and investment community with an overview of the KABN North America platform  KABN believes that ownership of identity is a basic human right and individuals should be the primary beneficiary of any use of their identity.  KABN’s product suite offers:
KABN North America has 4 primary products that enable users to verify, manage and monetize their digital identity:
KABN ID: a reusable, Always On, compliant, biometrically based, identity verification and validation platform that forms the engine of the KABN Network.
LIQUID AVATAR: a digital image-based “wallet and keyring†platform that allows users to manage their digital identity.
KABN Card: an approved prepaid Visa card that includes a mobile banking wallet that supports both digital and traditional currencies.
KABN KASH: a robust loyalty and engagement platform with cashback and card-linked programs.
Beacon Securities analyst Doug Cooper thinks the market has so far ignored a series of recent game-changing announcements by medical technology company MedX Health (MedX Health Stock Quote, Chart, News TSXV:MDX).
That scenario, said Cooper in a June 16 update to clients, makes for a prime investment opportunity.
Mississauga, Ontario-based MedX Health is developing non-invasive and cost-effective skin analysis and assessment systems for use by medical professionals. The company’s DermSecure telemedicine platform uses its SIAscopy technology which allows for images to be uploaded and sent to dermatologists for review.
MedX is now through its R&D phase with regulatory approval in 35 countries and has started commercialization.
MedX announced on Monday signing an exclusive distribution agreement to launch SIAscopy on DermSecure in Mexico through what it calls “an aggressive ease-of-access skin scanning/assessment program throughout Mexico†with partner company MedX Mexico.
MedX Mexico said it will be seeking regulatory approval, which it expects will come within the next 60 days, and then commence commercial sales.
According to the company, the opportunity in Mexico is significant, with skin cancer being a very common type of cancer in the country and with MedX’s already-established relationships there.
“MedX Mexico has experience in marketing medical devices and health solutions in the Mexican market, as well as a strong connections with hospitals, major pharmacies and medical clinics which will be a great benefit as it enters into this large market, and we are delighted to be partnering with them,†said Scott Spearn, who, as just announced on Thursday, will be stepping down immediately from the roles of president and CEO of MedX due to family reasons.
On the Mexico deal, Cooper called it, “just the latest in a series of game changing announcements from the company.â€
“Yet the stock has yet to react, which we believe creates excellent opportunity for investors. Over the past few months, it has announced new distribution relationships, the imminent commencement of a pharmacy trial in Canada and the closing of a $3.3 million private placement that provided the company with necessary growth capital,†Cooper wrote.
Cooper argued that with its medical device and platform MedX is filling an unmet medical need, where on a global scale melanoma continues to be mis-diagnosed and patients have long wait times to see a dermatologist, a problem as melanoma, if untreated, can become life threatening in as little as six weeks through spread to other parts of the body.
The analyst noted MedX’s Mexican announcement comes on the heels of its exclusive distribution partnership in Brazil (also with a significant skin cancer problem, Cooper says), while on the home front, Cooper said,
“We believe MedX is about to start a trial with a high profile pharmacy chain in Canada. Given the success of the ‘proof of concept’ trial with Boots Pharmacy in Norway, we believe this will not only be successful but will also increase the company’s exposure in the investment community,†Cooper wrote.
The analyst also said he thinks MedX is continuing meaningful conversations with potential partners in the United States and Europe, while also noting there could be an expansion in market opportunity to other conditions such as rosacea, acne and eczema.
Posted by AGORACOM-JC
at 8:23 AM on Friday, July 3rd, 2020
Empower is expanding its COVID-19 testing to five days per week to meet demand
June 2020 patient volume surpasses 2,100 patients visits, a company record for the month of June
VANCOUVER, BC / July 3rd, 2020 / EMPOWER CLINICS INC. (CSE:CBDT) (OTCQB:EPWCF) (Frankfurt:8EC) (“Empower” or the “Company“), a life sciences company, is pleased to announce the Company is expanding COVID-19 testing days to meet the increasing demand in the State of Arizona. In addition, the Company conducted 2,130 physician-patient consultations setting a new historic milestone in patient volume for the month of June.
“As a company and a health & wellness clinic operator, we are fortunate to be able to provide care and support to our thousands of patients each month.” said Steven McAuley, Chairman & CEO of Empower. “The demand for our services, are at an all-time high, requiring us to hire new staff and extend hours of operation. Our team continues to perform with complete professionalism, and safety, knowing the importance of the physician consultations we provide.”
The Arizona Department of Health Services has reported that in the last seven (7) days, nearly 25,000 positive cases of coronavirus have been reported, representing more than 25% of the total cases in the state of Arizona since the pandemic first started in late January 2020. Total reported cases now exceed 87,000 in the state.
As previously disclosed, the Company submitted an application for a management cease trade order (“MCTO“) with the British Columbia Securities Commission. The Company confirms that the BC Securities Commission has approved the application for the MCTO effective June 16, 2020
As required under section 9 b) of the National Policy 12-203 – Cease Trade Orders the Company indicates it is unable to meet the prescribed filing deadline due to additional audit requirements by its auditor MNP, LLP and due to increased operational limitations related to the coronavirus pandemic. The Company continues to expect to file the annual filings, no later than July 15, 2020.
The Company intends to comply with the provisions of the alternative information guidelines as set out in the National Policy 12-203 – Cease Trade Orders for Continuous Disclosure Defaults for as long as it remains in default, including the issuance of bi-weekly default status reports, each of which will be issued in the form of a news release.
As required under Canadian securities laws, the Company will provide a further update on or about July 14, 2020. Additionally, to the knowledge of the Company, there have been no material business developments as of the date of this news release that have not been generally disclosed.
ABOUT EMPOWER
Empower is a vertically integrated health & wellness company with a network of corporate and franchised health & wellness clinics in the U.S. The Company is focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The Company has launched Dosed Wellness Ltd. to connect its significant data, to the potential of the efficacy of alternative treatment options related to hemp-derived cannabidiol (CBD) therapies, psilocybin and other psychedelic plant-based treatment options.
For French inquiries: Remy Scalabrini, Maricom Inc., E: [email protected], T: (888) 585-MARI
DISCLAIMER FOR FORWARD-LOOKING STATEMENTS
This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release.Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include statements regarding: the Company’s expected timing of filing of its Annual Filings, the Company’s intention to create psilocybin and psychedelics divisions, that market research on advancements in psilocybin and psychedelics in North America and globally will create greater shareholder value, the Company’s intention to open a hemp-based CBD extraction facility, the expected benefits to the Company and its shareholders as a result of the proposed acquisitions and partnerships; the effectiveness of the extraction technology; the expected benefits for Empowers patient base and customers; the benefits of CBD based products; the effect of the approval of the Farm Bill; the growth of the Company’s patient list and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2019 and beyond; the ability of the Company to complete or execute phases One, Two, Three or Four of COVID-19 test programs, and Psychedelic substances remain illegal in most countries, so please reference your local laws in relation to medical or recreational use. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including; that the Company may not open a hemp-based CBD extraction facility; that legislative changes may have an adverse effect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed acquisitions and partnerships; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.
SOURCE: Empower Clinics Inc.
Tags: CBD, CSE, Dosed Movie, Dosed Wellness, Hemp Posted in Empower Clinics Inc., Featured | Comments Off on Empower $CBDT.ca #Covid19 Testing to Expand to Five Days Per Week and June 2020 Patient Visits Set Records $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca
Posted by AGORACOM-JC
at 6:02 PM on Thursday, July 2nd, 2020
When the Facebook data privacy scandal broke out, the world woke up to just how badly our individual data was being traded, used and most importantly, the amount of profit being generated by major corporations at our expense.
This led to the enactment of the biggest data privacy laws in history. Specifically, General Data Protection Regulation (GDPR) out of Europe and the California Consumer Privacy Act (CCPA).
Enter KABN. The Company Turns The Problem Of Data Privacy Into A Profit For Individuals, While Providing Big Businesses With New & Compliant Business Models.
KABN’s timing could not be more perfect.
Watch this interview with President David Lucatch and welcome to the next great disruptive industry of the decade!
Posted by AGORACOM-JC
at 2:42 PM on Thursday, July 2nd, 2020
Pelletization is the process in which iron ore is concentrated before shipment, thus significantly reducing the cost of transportation
In conventional technologies, the process heat is provided by fuel oil or natural gas burners (both environmentally damaging)
The combustion, in the burners, of fossil fuels results in the production of greenhouse gases, mainly CO2
Plasma torches, by contrast, utilize renewable electricity and as such offer an environmentally attractive alternative to fossil fuel burners
MONTREAL, July 02, 2020 — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX-V: PYR) (OTCQB: PYRNF) (FRA: 8PY), a high-tech company, (the “Company”, the “Corporation†or “PyroGenesis”) that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch systems, is pleased to provide today, further to  recent  press releases, an update on its iron ore pelletization torch business. Â
Client A On April 30th, 2020, the Company announced the successful completion of the first phase of a torch modeling contract with Client A which successfully demonstrated that replacing fossil fuel burners with PyroGenesis’ proprietary plasma torch (i) had absolutely no ancillary detrimental effects anywhere in the process or with their furnaces, (ii) resulted in significant greenhouse gas reduction while at the same time, (iii) projecting significant additional benefits. The subsequent phases were to be completed by June 30th, 2020 and were geared to further quantify the benefits of transitioning to plasma torches. These phases have been extended for up to six weeks with this additional data being incorporated into an ideal plasma torch configuration for this client.
Equipment purchase discussions are expected to be completed by the end of August, and incorporate the ideal plasma torch configuration identified during the modelling process, with the ultimate goal being to eliminate GHG emissions from all their plants.
Client B On June 11th, 2020 the Company announced that it had signed a second multi-phase torch modelling contract with Client B, aimed at evaluating the performance of PyroGenesis’ proprietary torches in an existing iron ore industrial furnace with the goal of replacing existing fossil fuel burners with PyroGenesis’ plasma torches. The first phase, as expected, is to be completed by mid-August.
During the first phase, which is progressing as expected, Client B has already entered into active equipment purchase discussions with PyroGenesis.
New Development – Client C A new potential client (“Client Câ€), who is not only a significant player in the iron ore pelletization industry but is also a major player in the steel industry, has entered into active equipment purchase discussions with the Company. There seems to be a high probability that Client C may bypass the modelling phase altogether, however it is PyroGenesis’ preference to incorporate a modeling phase if at all practical.
“Once again, although there is no certainty that any of these relationships will result in anything substantial, we are extremely pleased with the responses and the speed at which things are moving with this offering,†said Mr. Peter Pascali, CEO and President of PyroGenesis. “As would be prudent under the circumstances, PyroGenesis has taken steps to ensure that any reasonable requests from our clients can be met in a timely fashion, and to their full satisfaction. Barring any unforeseen events, we believe that it is entirely reasonable that initial torch equipment purchases will be placed in Q3 2020.â€
Pelletization is the process in which iron ore is concentrated before shipment, thus significantly reducing the cost of transportation. In conventional technologies, the process heat is provided by fuel oil or natural gas burners (both environmentally damaging). The combustion, in the burners, of fossil fuels results in the production of greenhouse gases, mainly CO2. Plasma torches, by contrast, utilize renewable electricity and as such offer an environmentally attractive alternative to fossil fuel burners.
About PyroGenesis Canada Inc. PyroGenesis Canada Inc., a high-tech company, is the world leader in the design, development, manufacture and commercialization of advanced plasma processes and products. We provide engineering and manufacturing expertise, cutting-edge contract research, as well as turnkey process equipment packages to the defense, metallurgical, mining, advanced materials (including 3D printing), oil & gas, and environmental industries. With a team of experienced engineers, scientists and technicians working out of our Montreal office and our 3,800 m2 manufacturing facility, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization. Our core competencies allow PyroGenesis to lead the way in providing innovative plasma torches, plasma waste processes, high-temperature metallurgical processes, and engineering services to the global marketplace. Our operations are ISO 9001:2015 and AS9100D certified, and have been since 1997. PyroGenesis is a publicly-traded Canadian Corporation on the TSX Venture Exchange (Ticker Symbol: PYR) and on the OTCQB Marketplace. For more information, please visit www.pyrogenesis.com.
This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward- looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Corporation’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Corporation with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Corporation’s ongoing filings with the securities regulatory authorities, which filings can be found at www.sedar.com, or at www.otcmarkets.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Corporation undertakes no obligation to publicly update or revise any forward- looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws. Neither the TSX Venture Exchange, its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) nor the OTCQB accepts responsibility for the adequacy or accuracy of this press release.
SOURCE PyroGenesis Canada Inc.
For further information please contact: Rodayna Kafal, Vice President Investors Relations and Strategic Business Development Phone: (514) 937-0002, E-mail: [email protected] RELATED LINK: http://www.pyrogenesis.com/
Posted by AGORACOM
at 10:29 AM on Thursday, July 2nd, 2020
Plethora now owns 13.92% of LabGold
Stichting Depositary Plethora Precious Metals Fund (“Plethoraâ€) announces that on June 26, 2020 it acquired 1,100,000 Units (hereinafter defined) of Labrador Gold Corp. (the “Companyâ€) at $0.175 per Unit pursuant to a private placement for gross proceeds of $192,500 (the “Acquisitionâ€). Each “Unit†acquired consists of one common share in the Company (a “Shareâ€) and one common share purchase warrant in the Company (a “Warrantâ€). Each Warrant entitles the holder thereof to acquire one Share for $0.30 until June 25, 2022.
Prior to this Acquisition, Plethora owned or controlled 8,579,000 Shares and 1,500,000 common share purchase warrants representing 16.12% of the Company’s issued and outstanding Shares on a partially diluted basis. On an undiluted basis, Plethora’s ownership before the Acquisition represented 14.05% of the Company’s issued and outstanding Shares. Following the Acquisition, Plethora now owns or controls an aggregate 9,679,000 Shares, and 2,600,000 common share purchase warrants, representing 13.92% of the issued and outstanding Shares on a partially diluted basis. On an undiluted basis, Plethora’s ownership after the Acquisition represents 11.31% of the Company’s issued and outstanding Shares.
In satisfaction of the requirements of National Instrument 62-104 – Take-Over Bids and Issuer Bids and National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider Reporting Issues, an early warning report respecting the acquisition of securities by Plethora will be filed under the Company’s SEDAR Profile at www.sedar.com.
Plethora acquired the Units for investment purposes only, and depending on market and other conditions, Plethora may from time to time in the future increase or decrease their ownership, control or direction over securities of the Company, through market transactions, private agreements, or otherwise.
Plethora is incorporated under the laws of the Netherlands and its head office is located at Prins Hendriklaan 26, 1075HD, Amsterdam, Netherlands. The principal business of Plethora is a Management Fund.
For information, please contact:
Douwe van Hees- Fund Manager Prins Hendriklaan 26 1075HD, Amsterdam Netherlands Phone: +3 16 14 51 46 92
About Labrador Gold:
Labrador Gold is a Canadian based mineral exploration company focused on the acquisition and exploration of prospective gold projects in the Americas.
In early March 2020, Labrador Gold acquired the option to earn a 100% interest in the Kingsway project in the Gander area of Newfoundland. The property is along strike to the northeast of New Found Gold’s discovery of 92.86 g/t Au over 19.0 metres on their Queensway property. (Note that mineralization hosted on adjacent or nearby properties is not necessarily indicative of mineralization hosted on the Company’s property). The two licenses comprising the Kingsway project cover approximately 16km of the Appleton fault zone which is associated with gold occurrences in the region, including the New Found Gold discovery. Historical work over the area covered by the Kingsway licenses shows evidence of gold in till, vegetation, soil, stream sediments, lake sediments and float. Infrastructure in the area is excellent located just 18km from the town of Gander with road access to the project, nearby electricity and abundant local water.
The Hopedale property covers much of the Florence Lake greenstone belt that stretches over 60 km. The belt is typical of greenstone belts around the world but has been underexplored by comparison. Initial work by Labrador Gold during 2017 show gold anomalies in soils and lake sediments over a 3 kilometre section of the northern portion of the Florence Lake greenstone belt in the vicinity of the known Thurber Dog gold showing where grab samples assayed up to 7.8g/t gold. In addition, anomalous gold in soil and lake sediment samples occur over approximately 40 kilometres along the southern section of the greenstone belt (see news release dated January 25th 2018 for more details).
The Ashuanipi gold project is located just 35 km from the historical iron ore mining community of Schefferville, which is linked by rail to the port of Sept Iles, Quebec in the south. The claim blocks cover large lake sediment gold anomalies that, with the exception of local prospecting, have not seen a systematic modern day exploration program. Results of the 2017 reconnaissance exploration program following up the lake sediment anomalies show gold anomalies in soils and lake sediments over a 15 kilometre long by 2 to 6 kilometre wide north-south trend and over a 14 kilometre long by 2 to 4 kilometre wide east-west trend. The anomalies appear to be broadly associated with magnetic highs and do not show any correlation with specific rock types on a regional scale (see news release dated January 18th 2018). This suggests a possible structural control on the localization of the gold anomalies. Historical work 30 km north on the Quebec side led to gold intersections of up to 2.23 grams per tonne (g/t) Au over 19.55 metres (not true width) (Source: IOS Services Geoscientifiques, 2012, Exploration and geological reconnaissance work in the Goodwood River Area, Sheffor Project, Summer Field Season 2011). Gold in both areas appears to be associated with similar rock types.
Posted by AGORACOM
at 10:01 AM on Thursday, July 2nd, 2020
Durango Resources Inc.’s exploration team has arrived on site at Windfall Lake, Quebec.
Preparing drill pads for upcoming summer drill program
The work crew has been tasked with preparing the site for the upcoming summer drill program by way of creating drill pads and clearing access to the areas of interest. As previously announced on April 4, 2019, Durango has identified 15 drill targets for the Trove Property to test favourable IP signatures that coincide with geochemistry anomalies including gold found in till samples.
The exploration team will also be mapping and collecting additional till and rock samples on the East Barry Block in an area of interest along the contact of instrusives and volcanics. Till sampling conducted in 2018 and 2019, identified a 5km trend which we are eager to investigate and identify the source for future drill targets.
Marcy Kiesman, chief executive officer of Durango, stated: “I am excited to finally get our exploration team moving at Windfall Lake. I want to thank our shareholders for their patience this year as we navigated the challenges of closures and increased regulations due to COVID19. We look forward to a busy summer exploring and drilling in the Windfall gold camp adjacent to Osisko with great hopes for success for our shareholders.”
The technical contents of this press release were approved by George Yordanov, professional geologist, an Independent Qualified Person as defined by National Instrument 43-101. The property has not yet been subject to an NI-43-101 report.
Trove, Quebec
Durango owns 100% interest in the Trove claims, which are surrounded by Osisko Mining Inc., in the Windfall Lake area between Val d’Or and Chibougamau, Quebec. The 1,185 hectare property is compelling due to the coincidence of gold found in tills coinciding with magnetic highs, several Induced Polarization (“IP”) anomalies and two faults crosscutting the property. The fault systems north and south of the Trove, control gold mineralization elsewhere, indicating the Trove has excellent exploration potential. Durango received all the final drill permits for the Trove property in September 2019 and is undergoing its final reviewing process for the proposed 3,000m drill program.
East Barry, Quebec
Durango owns 100% interest in the East Barry claims which run parallel to Trove claims. The East Barry block is over 6,100 hectares in size and borders the eastern perimeter of Osisko’s holdings and the southern perimeter of Bonterra’s holdings and is less than 4km south of the Gladiator deposit. The East Barry claims host a gold trend which covers approximately 10km in length and is subparallel to the main Barry Fault held by Osisko. In 2018 a till sampling program was conducted and one of the till samples returned fourty-two (42) pristine gold grains with reported gold values of 2.184 g/t Au. A high count of pristine gold grains indicates that the gold has travelled a very short distance from its source. The East Barry block underwent an Induced Polarization (“IP”) survey in 2018 which identified a high priority target coincident with the high count of pristine gold grains.
About Durango
Durango is a natural resources company engaged in the acquisition and exploration of mineral properties. The Company is positioned for discovery with a 100% interest in a strategically located group of properties in the Windfall Lake gold camp in the Abitibi region of Quebec, Canada.
Beacon Securities analyst Doug Cooper thinks the market has so far ignored a series of recent game-changing announcements by medical technology company MedX Health (
